https:/#/nc.emagedd.www/ - Search

Články časopisu Genomic rearrangements generate hypervariable mini-chromosomes in host-specific isolates of the blast fungus

Author of the article: Thorsten Langner, Adeline Harant, Luis B. Gomez-Luciano, Ram K. Shrestha, Angus Malmgren, Sergio M. Latorre, Hernán A. Burbano, Joe Win, Sophien Kamoun Source: PLOS Genetics | 2/2021 4. 2. 2021

Články časopisu Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study

Author of the article: Robyn E. Elphinstone, Andrea M. Weckman, Chloe R. McDonald, Vanessa Tran, Kathleen Zhong, Mwayiwawo Madanitsa, Linda Kalilani-Phiri, Carole Khairallah, Steve M. Taylor, Steven R. Meshnick, Victor Mwapasa, Feiko O. ter Kuile, Andrea L. Conroy, Kevin C. Kain Source: PLOS Medicine | 10/2019 2. 10. 2019

Články časopisu Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with haemophilia, 3rd edition, year 2021

Author of the article: Pracovní Skupina Čnhp Pro Standardy:, P. Smejkal, J. Blatný, Z. Hajšmanová, A. Hluší, R. Hrdličková, E. Zápotocká, M. Penka, Rady Koordinační Jménem, Výkonné Rady Čnhp:, B. Blažek, Z. Čermáková, Z. Černá, P. Ďulíček, J. Hak, V. Komrska, P. Ovesná, D. Pospíšilová, D. Procházková, P. Timr, J. Ullrychová, I. Vonke, L. Walterová Source: Transfuze a hematologie dnes | 1/2021 15. 3. 2021

Články časopisu Vascular endothelial growth factor D potential predictor and screening marker in ovarian carcinoma

Author of the article: Monika Náležinská, Josef Chovanec Source: Česká gynekologie | 1/2025 18. 3. 2025

News Impact of Alpha-1 Antitrypsin Deficiency on Quality of Life and Mental Health of Patients

The clinical manifestation of alpha-1 antitrypsin deficiency and its impact on quality of life are highly heterogeneous. This contribution by pulmonologist Robert Sandhaus summarizes interesting findings from studies on the quality of life of patients with this disease and the factors influencing it.

Source: Deficiency of Alpha-1-Antitrypsin 3. 11. 2020

News Should patients with primary immunodeficiencies fear COVID-19 more than the general population?

The body fights the new SARS-CoV-2 virus, which causes COVID-19, in a similar way to other viral infections -⁠ by intensely engaging the immune system. But what if it's weakened?

Source: Primary and Secondary Immunodeficiencies 7. 5. 2020

News Dressing Solutions for Better Wound Care

Although wounds at different stages of healing require different types of treatment, the essential part of any dressing change is cleaning the wound and its surroundings from tissue debris and microorganisms and protecting it from reinfection. Modern dressing solutions facilitate easy cleaning and moisturizing of wounds. Effective treatment also brings clinical and economic benefits.

Source: Wound Healing 19. 3. 2023

News Alarming Data on Prevalence and Insufficient Treatment of Hypertension in Working Age −⁠ Another Underestimated 'Civilization Epidemic'?

The National Cardiology Information System (NKIS), developed by the Czech Society of Cardiology in collaboration with the Institute of Health Information and Statistics (ÚZIS), has provided the first data on the prevalence of hypertension in the Czech population. It revealed that even the treatment of a significant risk factor for cardiovascular diseases –⁠ hypertension –⁠ is not well managed in the Czech Republic. About 40% of patients with hypertension do not have regular preventive check-ups with their general practitioner, while 40% of hypertensive patients are simultaneously of working age.

Source: Risk factors of cardiovascular diseases 10. 6. 2024

News What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?

A Spanish clinical study monitored the effect of administering probiotics as an adjunct therapy to non-surgical mechanical treatment of peri-implantitis. What did the study show regarding the effect on microbiome composition and overall clinical picture when a preparation containing Limosilactobacillus reuteri Prodentis was administered?

Source: Dental Care 7. 6. 2024

News More Patients Will Now Have Access to Incontinence Aids

Since December of last year, new rules have been in effect for the prescription of medical aids prescribed through vouchers, including aids for urine collection and voiding. The new rules are governed by the current wording of Act No. 48/1997 Coll., on Public Health Insurance, which also includes a new categorization tree (Appendix No. 3 to the Act).

Source: Incontinence 3. 3. 2020

News Prescription Restrictions on Antidiabetics Authorized for Prescription by General Practitioners -⁠ Status as of October 2020

Diabetes mellitus (DM) has become an increasing problem worldwide in recent years. Long-term complications of DM lead to increased morbidity and mortality in the diabetic population, and their prevention determines the main treatment goals of DM. The treatment and management of patients with type 2 diabetes (DM2) are provided by either a general practitioner's office (GP) or a diabetology clinic. According to available data, over 200,000 patients with DM2 are currently treated and managed in GP offices.

Source: Diabetes 15. 10. 2020

News Metamizole in the Treatment of Acute Postoperative Pain

In many countries, metamizole is considered a first-choice non-opioid analgesic. The analysis presented below, published in the Cochrane Database of Systematic Reviews, examined the efficacy and safety of metamizole in the treatment of acute postoperative pain.

Source: Analgesia 25. 5. 2021

News Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches

The aim of the review article by Brazilian authors was to summarize the efficacy and safety of metamizole in the treatment of acute primary headaches, such as migraine, episodic tension-type headache (ETTH), cluster headache, and unclassified primary pain in adults and children.

Source: Analgesia 26. 10. 2020

News A Decade of Therapy Targeting B Lymphocytes in MS

Ocrelizumab is not only a pioneer but also a highly effective and still promising modality for the treatment of multiple sclerosis (MS) with excellent patient adherence and persistence.

Source: Neurology - Multiple Sclerosis 3. 1. 2024

News INFOGRAPHIC: Which treatment to choose in the 1st line for a patient with type 2 diabetes?

Diabetes mellitus is a complex chronic disease that requires continuous treatment and a strategy to reduce associated risks beyond mere glycemic control. Comorbidities and the risk of complications are key elements in deciding the choice of therapy for type 2 diabetics. This fact is also considered by the American Diabetes Association (ADA) in its annually published standards of care for patients with diabetes, which brought several changes in 2022.

Source: Diabetes 24. 2. 2023